Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $249,082 (100.0% shares, 0.0% debt)

Holdings (34)

GLPG GALAPAGOS ADR REP 13.5%
Value ($000) $33,630 Shares 827,294 Est. Cost $45.08 Unrealized
MGTX MEIRAGTX HOLDINGS 11.4%
Value ($000) $28,436 Shares 4,050,714 Est. Cost $7.75 Unrealized -36.3%
STTK SHATTUCK LABS 8.0%
Value ($000) $19,841 Shares 2,782,797 Est. Cost $4.75 Unrealized -42.6%
MDT MEDTRONIC 7.3%
Value ($000) $18,124 Shares 220,000 Est. Cost $76.21 Unrealized -6.2%
ORIC ORIC PHARMACEUTICALS 5.8%
Value ($000) $14,520 Shares 1,578,263 Est. Cost $4.85 Unrealized +49.2%
KURA KURA ONCOLOGY 5.5%
Value ($000) $13,661 Shares 950,000 Est. Cost $11.32 Unrealized -13.1%
BCRX BIOCRYST PHARMACEUTICALS 5.4%
Value ($000) $13,371 Shares 2,232,242 Est. Cost $8.75 Unrealized -33.8%
ADCT ADC THERAPEUTICS 4.3%
Value ($000) $10,743 Shares 6,471,800 Est. Cost $2.87 Unrealized -67.9%
ABCL ABCELLERA BIOLOGICS 3.9%
Value ($000) $9,707 Shares 1,700,000 Est. Cost $7.78 Unrealized -40.5%
QDEL QUIDELORTHO 3.5%
Value ($000) $8,764 Shares 118,920 Est. Cost $85.35 Unrealized -20.8%
PCRX PACIRA BIOSCIENCES 3.5%
Value ($000) $8,719 Shares 258,424 Est. Cost $39.77 Unrealized -26.4%
MIRM MIRUM PHARMACEUTICALS 3.5%
Value ($000) $8,658 Shares 293,301 Est. Cost $23.37 Unrealized +29.5%
PRTA PROTHENA 3.3%
Value ($000) $8,341 Shares 229,539 Est. Cost $36.66 Unrealized +5.0%
OPCH OPTION CARE HEALTH 2.0%
Value ($000) $5,013 Shares 148,800 Est. Cost $30.74 Unrealized -0.0%
GALAPAGOS ADR REP 2.0%
Value ($000) $4,878 Shares 120,000 Est. Cost $40.65 Unrealized
NBIX NEUROCRINE BIOSCIENCES 1.9%
Value ($000) $4,730 Shares 35,900 Est. Cost $100.70 Unrealized +14.3%
UHS UNIVERSAL HEALTH SERVICES CL B 1.7%
Value ($000) $4,282 Shares 28,090 Est. Cost $135.05 Unrealized -1.3%
GRAPHITE BIO 1.4%
Value ($000) $3,542 Shares 1,351,939 Est. Cost $2.94 Unrealized
KEZAR LIFE SCIENCES 1.3%
Value ($000) $3,188 Shares 3,365,333 Est. Cost $4.51 Unrealized
NUVB NUVATION BIO CL A 1.2%
Value ($000) $3,096 Shares 2,050,000 Est. Cost $1.50 Unrealized -14.1%
KIDS ORTHOPEDIATRICS 1.2%
Value ($000) $3,088 Shares 95,000 Est. Cost $29.00 Unrealized 0.0%
PRVA PRIVIA HEALTH GROUP 1.2%
Value ($000) $3,044 Shares 132,158 Est. Cost $22.38 Unrealized 0.0%
DXCM DEXCOM 1.1%
Value ($000) $2,854 Shares 23,000 Est. Cost $112.73 Unrealized -9.4%
MURAL ONCOLOGY 1.0%
Value ($000) $2,478 Shares 418,505 Est. Cost $5.92 Unrealized
PROTHENA 0.8%
Value ($000) $1,944 Shares 53,500 Est. Cost $36.34 Unrealized
MDRX VERADIGM 0.8%
Value ($000) $1,888 Shares 180,000 Est. Cost $12.26 Unrealized 0.0%
ORIC PHARMACEUTICALS 0.7%
Value ($000) $1,840 Shares 200,000 Est. Cost $9.20 Unrealized
BBSI BARRETT BUSINESS SERVICES 0.6%
Value ($000) $1,505 Shares 13,000 Est. Cost $22.58 Unrealized +12.1%
ERAS ERASCA 0.5%
Value ($000) $1,277 Shares 599,458 Est. Cost $2.70 Unrealized -21.9%
SYRE SPYRE THERAPEUTICS 0.5%
Value ($000) $1,184 Shares 55,000 Est. Cost $13.78 Unrealized 0.0%
SHOCKWAVE MEDICAL 0.4%
Value ($000) $953 Shares 5,000 Est. Cost $190.56 Unrealized
DSGN DESIGN THERAPEUTICS 0.3%
Value ($000) $742 Shares 280,000 Est. Cost $4.66 Unrealized -50.9%
BMEA BIOMEA FUSION 0.3%
Value ($000) $624 Shares 42,991 Est. Cost $18.03 Unrealized -32.6%
ALKS ALKERMES 0.2%
Value ($000) $416 Shares 15,000 Est. Cost $26.01 Unrealized -0.1%